Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model |
Stanford University / Michelle Monje, MD/PhD |
Innovation Grants |
2016 |
California |
Image Guided Diffuse Intrinsic Pontine Glioma Drug Delivery and Design |
Weill Cornell Medical College / Mark Souweidane, MD & Richard Ting, PhD |
Innovation Grants |
2016 |
New York |
GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death |
Boston Children’s Hospital / Dr. Ben Croker, PhD |
Innovation Grants |
2016 |
Massachusetts |
Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia |
University of Rochester / Craig Mullen, MD/PhD |
Innovation Grants |
2016 |
New York |
MYC as a Driver and Anti-Cancer Target in Malignant Rhabdoid Tumors |
Vanderbilt University Medical Center / William Tansey, PhD |
Innovation Grants |
2016 |
Tennessee |
Targeting the Function of Ezrin in Rhabdomyosarcoma |
The Cleveland Clinic Foundation / Neetu Gupta, PhD & Peter Anderson, MD |
Innovation Grants |
2016 |
Ohio |
Selective Epigenetic Regulation of Notch1 in T-cell Acute Lymphoblastic Leukemia |
University of Michigan / Mark Yat-Fung Chiang, MD/PhD |
Innovation Grants |
2016 |
Michigan |
Sepsis as innate immune stimulus: severe sepsis exposures and protection against relapse in children with acute leukemias |
Children’s Hospital of Philadelphia / Alix Seif, MD |
Epidemiology Grants |
2016 |
Pennsylvania |
Child's Exposure to Radiation from Medical Imaging and the Risk of Childhood Leukemia: Pooled Analyses from the Childhood Leukemia International Consortium (CLIC) |
University of California Berkeley / Catherine Metayer, MD/PhD & Steve Selvin, PhD |
Epidemiology Grants |
2016 |
California |
The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis |
Washington University / Jeffrey Magee, MD/PhD |
'A' Award Grants |
2016 |
Missouri |